While we noted a reduction in injury and inflammation in both MASH models treated with LIE sgRNA, consistent with etiological reversal, we also asked whether S100A11 may have direct effects on hepatic stellate cells via its cognate receptor, the receptor for advanced glycation end products (RAGE). The gene discussed is AGER; the disease is metabolic dysfunction-associated steatohepatitis.